INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2010

Acute ingestion of Hibiscus sabdariffa extract decreased plasma monocyte chemoattractant protein-1 in humans

Researchers examined the anti-inflammatory effects of an aqueous Hibiscus sabdariffa extract in cultured blood cells and in a human clinical trial. In humans, acute ingestion of a 10 g dose was well tolerated and significantly reduced plasma concentrations of monocyte chemoattractant protein-1. The treatment did not alter other inflammatory cytokines or elevate plasma antioxidant capacity.

Study type
Acute clinical trial and in vitro study
Who was studied
Human volunteers (sample size not stated)
What was measured
Plasma MCP-1 and cytokine concentrations

THE PAPER

The aqueous extract of Hibiscus sabdariffa calices modulates the production of monocyte chemoattractant protein-1 in humans.

Beltrán-Debón R, Alonso-Villaverde C, Aragonès G, Rodríguez-Medina I, Rull A, Micol V, Segura-Carretero A, Fernández-Gutiérrez A, Camps J, Joven J. Phytomedicine, 2010.

PubMed 19765963 ↗DOI 10.1016/j.phymed.2009.08.006 ↗

Other health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.